- Retraction Note
- Open access
- Published:
Retraction Note: MicroRNA-375 released from extracellular vesicles of bone marrow mesenchymal stem cells exerts anti-oncogenic effects against cervical cancer
Stem Cell Research & Therapy volume 15, Article number: 51 (2024)
The Original Article was published on 27 October 2020
Stem Cell Research & Therapy (2020) 11:455
Retraction note
The Editors-in-Chief have retracted this article. After publication, concerns were raised regarding similar features between this article and a number of other articles on non-coding RNAs from different research groups published within a similar time frame [1,2,3,4]. Specifically, the ruler in Fig. 7A appears highly similar to that in the tumour images presented in [1,2,3,4]. The shapes and backgrounds on the western blots presented in all figures in this article also appear highly similar to those in the aforementioned articles. Additionally, Fig. 3D NC-inhibitor and miR-375 inhibitor images appear highly similar.
The Editors-in-Chief therefore no longer have confidence in the presented data.
None of the authors have responded to any correspondence from the editor or publisher about this retraction.
References
Zhou N, Qiao H, Zeng M, et al. RETRACTED ARTICLE: Circ_002117 binds to microRNA-370 and promotes endoplasmic reticulum stress-induced apoptosis in gastric cancer. Cancer Cell Int. 2020;20:465. https://doi.org/10.1186/s12935-020-01493-4.
Xin R, Qu D, Xu H, et al. RETRACTED ARTICLE: circ_001504 promotes the development of renal cell carcinoma by sponging microRNA-149 to increase NUCB2. Cancer Gene Ther. 2021;28:667–78. https://doi.org/10.1038/s41417-020-00247-8.
Li L, Gao Z, Zhao L, Ren P, Shen H. Long non-coding RNA LINC00607 silencing exerts antioncogenic effects on thyroid cancer through the CASP9 promoter methylation. J Cell Mol Med. 2021;25:7608–20. https://doi.org/10.1111/jcmm.16265.
Jia Y, Ding X, Zhou L, et al. RETRACTED ARTICLE: mesenchymal stem cells-derived exosomal microRNA-139-5p restrains tumorigenesis in bladder cancer by targeting PRC1. Oncogene. 2021;40:246–61. https://doi.org/10.1038/s41388-020-01486-7.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s13287-020-01908-z.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Ding, F., Liu, J. & Zhang, X. Retraction Note: MicroRNA-375 released from extracellular vesicles of bone marrow mesenchymal stem cells exerts anti-oncogenic effects against cervical cancer. Stem Cell Res Ther 15, 51 (2024). https://doi.org/10.1186/s13287-024-03666-8
Published:
DOI: https://doi.org/10.1186/s13287-024-03666-8